ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TMMG The Mission Marketing Group Plc

78.50
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group Plc LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 78.50 77.00 80.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

The Mission Marketing Group PLC Acquisition of RJW & Partners (5137D)

27/04/2017 7:40am

UK Regulatory


The Mission Marketing (LSE:TMMG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more The Mission Marketing Charts.

TIDMTMMG

RNS Number : 5137D

The Mission Marketing Group PLC

27 April 2017

The Mission Marketing Group plc

Acquisition of RJW & Partners

The Mission Marketing Group plc ('the mission(tm) ', "the Company", AIM: TMMG), the marketing communications and advertising group, is pleased to announce that it has acquired RJW & Partners Ltd ('RJW'), a company providing consultancy services to the pharmaceutical and medical devices industries, working in pricing, market access and payer communications. Initial consideration is GBP1.75m for the business and GBP0.23m for cash balances held. GBP1.88m is payable in cash and GBP0.1m will be satisfied through the issue of 237,117 new ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares"). Further consideration of up to GBP4.25m is payable subject to financial performance in 2017, 2018, 2019, and 2020, of which 5% is payable in shares and 95% payable in cash.

About RJW

Established in 2008, RJW is a UK-based consultancy with around 30 employees and external consultants who specialise in pricing and market access strategy, tactics and communications in all major markets and world regions. The Company works with a wide range of clients in the pharmaceutical sector, including AstraZeneca, Shire and Novartis. RJW will operate as part of Mission Healthcare, adding an important and new global market access capability to the mission(tm) 's existing skills in medical communications.

In the 12 months to 31 March 2016, RJW had a turnover of GBP1.6 million, profits of GBP0.4 million and at 31 March 2016, had total assets of GBP0.2 million.

Commenting, David Morgan, Executive Chairman of the mission(tm) said:

"I am delighted to welcome RJW to the mission(tm) portfolio. The addition of RJW provides us with a world-class team in the fast-growing specialism of pricing and market access.

We are confident that the addition of this capability to our strong marketing communication credentials will provide an enormously compelling Healthcare offer for existing and new Clients alike. We look to the future of Mission Healthcare with great excitement."

Neil Johnson, Director of RJW said:

"We are extremely pleased to be joining the mission(tm) Healthcare team. We are convinced that in the mission(tm) we have found the perfect partner with which to grow."

Application has been made for the 237,117 new Ordinary Shares issued as initial consideration, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, to be admitted to trading on AIM, which is expected to be effective from 8.00 am on 4 May 2017. Subsequent to the issue of these new Ordinary Shares, the total issued share capital of the Company will be 84,357,351 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, after Admission, the total number of voting rights in the Company will be 84,357,351.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 
 Enquiries: 
 The Mission Marketing Group 
  plc                                020 7462 1415 
 David Morgan, Executive Chairman 
  Peter Fitzwilliam, Finance 
  Director 
 
 finnCap Limited                     020 7220 0500 
 Geoff Nash/James Thompson 
  (Corporate Finance) 
  Stephen Norcross (Corporate 
  Broking) 
 

the mission(tm) is a network of entrepreneurial marketing communications Agencies employing 1,000 people in the UK, Asia and US. The Group comprises three divisions: Integrated Generalists, Sector Specialists and Activity Specialists, which work together to provide Clients with the expertise and resource to make them more successful in today's challenging environment.

www.themission.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACQGLGDSIXDBGRR

(END) Dow Jones Newswires

April 27, 2017 02:40 ET (06:40 GMT)

1 Year The Mission Marketing Chart

1 Year The Mission Marketing Chart

1 Month The Mission Marketing Chart

1 Month The Mission Marketing Chart

Your Recent History

Delayed Upgrade Clock